BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 16485882)

  • 1. The use of photodynamic therapy in dermatology: results of a consensus conference.
    Nestor MS; Gold MH; Kauvar AN; Taub AF; Geronemus RG; Ritvo EC; Goldman MP; Gilbert DJ; Richey DF; Alster TS; Anderson RR; Bank DE; Carruthers A; Carruthers J; Goldberg DJ; Hanke CW; Lowe NJ; Pariser DM; Rigel DS; Robins P; Spencer JM; Zelickson BD
    J Drugs Dermatol; 2006 Feb; 5(2):140-54. PubMed ID: 16485882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatments of actinic keratosis.
    Gold MH; Nestor MS
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer.
    Garcia-Zuazaga J; Cooper KD; Baron ED
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):791-800. PubMed ID: 16221049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical photodynamic therapy in clinical dermatology.
    Kormeili T; Yamauchi PS; Lowe NJ
    Br J Dermatol; 2004 Jun; 150(6):1061-9. PubMed ID: 15214890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going.
    Gold MH; Goldman MP
    Dermatol Surg; 2004 Aug; 30(8):1077-83; discussion 1083-4. PubMed ID: 15274696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminolevulinic acid-photodynamic therapy for photorejuvenation.
    Nootheti PK; Goldman MP
    Dermatol Clin; 2007 Jan; 25(1):35-45. PubMed ID: 17126740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
    Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
    J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments?
    Morton CA
    J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The wider application of photodynamic therapy in dermatology].
    Thissen MR; Kuijpers DI; Neumann HA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):232-7. PubMed ID: 15719833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy.
    Rivard J; Ozog D
    J Drugs Dermatol; 2006 Jun; 5(6):556-61. PubMed ID: 16774110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
    Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis.
    Jeffes EW
    J Dermatolog Treat; 2002; 13 Suppl 1():S19-23. PubMed ID: 12060513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminolevulinic acid photodynamic therapy: medical evidence for its expanded use.
    Gold MH
    Expert Rev Med Devices; 2006 May; 3(3):357-71. PubMed ID: 16681457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers.
    Alexiades-Armenakas M
    Dermatol Clin; 2007 Jan; 25(1):25-33. PubMed ID: 17126739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
    Basset-Seguin N
    Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.